These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12760850)

  • 1. Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States.
    Karlowsky JA; Thornsberry C; Critchley IA; Jones ME; Evangelista AT; Noel GJ; Sahm DF
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1790-7. PubMed ID: 12760850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study.
    Thornsberry C; Ogilvie PT; Holley HP; Sahm DF
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2612-23. PubMed ID: 10543737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study.
    Critchley IA; Brown SD; Traczewski MM; Tillotson GS; Janjic N
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4382-9. PubMed ID: 17908940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.
    Thornsberry C; Jones ME; Hickey ML; Mauriz Y; Kahn J; Sahm DF
    J Antimicrob Chemother; 1999 Dec; 44(6):749-59. PubMed ID: 10590275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 6. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
    Thornsberry C; Ogilvie P; Kahn J; Mauriz Y
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):249-57. PubMed ID: 9458982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
    Zhanel GG; Palatnick L; Nichol KA; Low DE; Hoban DJ;
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1875-81. PubMed ID: 12760861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.
    Jorgensen JH; Doern GV; Maher LA; Howell AW; Redding JS
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2075-80. PubMed ID: 2127342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998.
    Sahm DF; Jones ME; Hickey ML; Diakun DR; Mani SV; Thornsberry C
    J Antimicrob Chemother; 2000 Apr; 45(4):457-66. PubMed ID: 10747822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents.
    Blondeau JM; Vaughan D; Laskowski R; Borsos S;
    Int J Antimicrob Agents; 2001 Jun; 17(6):457-64. PubMed ID: 11397615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
    Kärpänoja P; Nyberg ST; Bergman M; Voipio T; Paakkari P; Huovinen P; Sarkkinen H;
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2480-5. PubMed ID: 18443116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme.
    Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
    J Antimicrob Chemother; 2003 Dec; 52(6):931-43. PubMed ID: 14585865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance among respiratory pathogens collected in Thailand during 1999-2000.
    Critchley IA; Blosser-Middleton R; Jones ME; Yamakita J; Aswapokee N; Chayakul P; Tharavichitukul P; Vibhagool A; Thornsberry C; Karlowsky JA; Sahm DF
    J Chemother; 2002 Apr; 14(2):147-54. PubMed ID: 12017369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
    Morrissey I; Robbins M; Viljoen L; Brown DF
    J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the activity of ciprofloxacin and levofloxacin with other agents against respiratory tract pathogens.
    Wise R; Andrews JM
    J Chemother; 1998 Aug; 10(4):276-9. PubMed ID: 9720464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacodynamic activities of ABT-492, a novel quinolone, compared to those of levofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
    Gunderson SM; Hayes RA; Quinn JP; Danziger LH
    Antimicrob Agents Chemother; 2004 Jan; 48(1):203-8. PubMed ID: 14693540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002.
    Mendes C; Kiffer CR; Blosser-Middleton RS; Jones ME; Karlowsky JA; Barth A; Rossi F; Andrade S; Sader HS; Thornsberry C; Sahm DF;
    Clin Microbiol Infect; 2004 Jun; 10(6):521-6. PubMed ID: 15191379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001.
    Jones ME; Blosser-Middleton RS; Critchley IA; Karlowsky JA; Thornsberry C; Sahm DF
    Clin Microbiol Infect; 2003 Jul; 9(7):590-9. PubMed ID: 12925097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.